• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Markets in Q3: Bears in the China shop

September 30, 2021 by David Barret Leave a Comment

September 30, 2021

By Marc Jones and Julien Ponthus

LONDON (Reuters) – Some of the heaviest falls ever seen in China’s markets, huge energy price rises and the clearest signs yet that central banks are starting to turn off the money taps have all hit world markets over the last quarter.

A regulatory crackdown in China has wiped a trillion dollars off its markets and sent giants such as Alibaba tumbling 30% in their worst quarter on record, while property firm Evergrande, one of the world’s biggest high-yield debt issuers, is on the brink of default.

World stocks meanwhile are headed for their first quarter of losses since COVID-19 began to take its toll early last year, bonds have had a shaky September amid taper talk, and the safe-haven dollar is gunning for its best year since 2015.

At the same time, inflation is gathering pace on the back of rising commodity and shipping costs. Natural gas is up nearly 60% since July and 120% this year, coffee is up 25% for the second quarter in a row and freight costs have risen another 40%.

Emmanuel Cau, head of European equities at Barclays, reckons markets are pricing the end of the ‘Goldilocks’ scenario – when growth and inflation are neither too high nor too low – so investors should be aware of the bears.

“The end of Q3 is somewhat a foretaste of what’s to come with central banks starting to shift policies,” Cau said, noting a “brutal regime change” as investors switch from sectors such as tech into so-called value shares such as banks and energy.

“One also needs to take into account that Chinese growth will be weaker moving forward.”

For a graphic on Global markets in 2021 and Q3:

https://ift.tt/2Y3MNOg

CHINA SMASHED

The biggest drama was in Chinese markets where a crackdown on tech, digital and for-profit education firms deepened, followed by the Evergrande meltdown.

It all added up to a near trillion-dollar slide in Chinese equities, a 70% slump in Evergrande shares and a 14% bashing for anyone invested in high-yield Chinese corporate debt.

China’s worries meant MSCI’s emerging equity index dropped almost 10% after five quarters of gains and its underperformance versus Wall Street has been an eye-watering 30 percentage points.

“This has been one of the most value-destructive periods for Chinese equity markets in history,” said William Mileham at Swiss-based asset manager Mirabaud, adding that it felt like the regulatory pressures might not end.

For a graphic on China’s stocks slammed by clampdowns:

https://ift.tt/3D25zoq

The rising dollar also complicated life for other emerging markets, with the Chilean, Brazilian and Peruvian currencies down 7% to 9% over the quarter.

Turkey’s lira lost more ground after a recent surprise interest rate cut, remaining the year’s worst performer.

For a graphic on China’s high market market pounded by Evergrande default worries:

https://ift.tt/3oqvlib

STOCKS SPLICED

World stock markets are ending the quarter in disorderly fashion, with MSCI’s global index down around 1%, its first quarterly first loss since early 2020.

Pandemic plays Zoom and Peloton have lost about a third of their value, but vaccine makers Moderna and Pfizer are up 60% and 11% respectively, and aeroplane engine maker Rolls Royce has soared over 40%.

For many investors, September will likely be remembered as the end of a financial fairy tale when fiscal and monetary stimulus combined with buoyant growth and moderate inflation relentlessly kept pushing stock prices to record highs.

Rising yields have already prompted a brutal rotation within equity portfolios as managers typically dumped growth and tech stocks for cheaper shares in the banking and oil and gas industries.

The Nasdaq came off 2% over the quarter but lost about 4.5% in September as sell-side analysts encouraged their clients to go for “value” and cut risk out of FAANGS. Even Amazon has lost ground.

“It is a very, very challenging time to build a portfolio”, said Roland Kaloyan, who heads Societe Generale’s European equity strategy.

“At the same time you want to have exposure to rising yields, hedge against rising yields and hedge your portfolio against slowing growth in China”.

For a graphic on MSCI Value vs Growth and Bund yields:

https://ift.tt/3kVF2Dl

BONDS – NO TIME TO BUY

Bond markets, after a huge July rally, tumbled in September after hawkish turns from the U.S. Federal Reserve and the Bank of England, giving global government bond buyers a rare loss of 1%.

Clear third-quarter winners were inflation-linked bonds in the euro area and Britain, with returns of some 3% each, according to ICE BofA indexes. These securities are benefiting from fears that inflation spurred by supply-chain disruptions and labour shortages will be less transitory than flagged..

Globally there have now been more than 50 separate interest rate hikes this year, led by emerging market inflation hotspots like Brazil and Russia.

On credit markets, away from China’s turbulence, the lowest-rated “junk” euro corporate debt — at Triple C or lower — have returned around 1.4% as companies continue to recover from the pandemic.

For a graphic on Global FX year to date:

https://ift.tt/39PioGc

(Reporting by Marc Jones and Julien Ponthus; Additional reporting by Sujata Rao, Danilo Masoni and Yoruk Bahceli; Editing by Hugh Lawson)

Source Link Markets in Q3: Bears in the China shop

David Barret
David Barret

Related posts:

  1. Australia’s treasurer says economy must diversify from China reliance
  2. China Evergrande bonds suspended as prices slump
  3. At unfinished Evergrande apartments in central China, buyers seek answers
  4. U.S. sanctions several Hong Kong-based Chinese entities over Iran -website

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • If Birds Are Dinosaurs, Why Are None As Big As T. Rexes?
  • Psychologists Demonstrate Illusion That Could Be Screwing Up Our Perception Of Time
  • Why Are So Many Enormous Roman Shoes Being Discovered At Hadrian’s Wall?
  • Scientists Think They’ve Pinpointed Structural Differences In Psychopaths’ Brains
  • We’ve Found Our Third-Ever Interstellar Visitor, Orcas Filmed Kissing (With Tongues) In The Wild, And Much More This Week
  • The “Eyes Of Clavius” Will Be Visible On The Moon Today, Thanks To Clair-Obscur Effect
  • Shockingly High Microplastic Levels Found On Remote Mediterranean Coral Reef Island
  • Interstellar Object, Cheesy Nightmares, And Smooching Orcas
  • World’s Largest Martian Meteorite Up For Auction Could Reach Whopping $2-4 Million
  • Kimalu The Beluga Whale Undergoes Pioneering Surgery And Becomes First Beluga To Survive General Aesthetic
  • The 1986 Soviet Space Mission That’s Never Been Repeated: Mir To Salyut And Back Again
  • Grisly Incident In Yellowstone National Park Shows Just How Dangerous This Vibrant Wilderness Can Be
  • Out Of All Greenhouse Gas Emitters On Earth, One US Organization Takes The Biscuit
  • Overly Ambitious Adder Attempts To Eat Hare 10 Times Its Mass In Gnarly Video
  • How Fast Does A Spacecraft Need To Go To Escape The Solar System?
  • President Trump’s Cuts To USAID Could Result In A “Staggering” 14 Million Avoidable Deaths By 2030
  • Dzo: Hybrids Beasts That Are Perfectly Crafted For Life On Earth’s Highest Mountains
  • “Rarest Event Ever” Had A Half-Life 1 Trillion Times Longer Than The Age Of The Universe – How Did We See It?
  • Meet The Bille, A Self-Righting Tetrahedron That Nobody Was Sure Could Exist
  • Neurogenesis Confirmed: Adult Brains Really Do Make New Hippocampal Neurons
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version